UK Hospital Trials 60-Second Test for Winter Respiratory Infections
University Hospital Southampton is trialing a point-of-care biosensor test for flu, COVID-19, and RSV, delivering results in four minutes, according to the hospital.
University Hospital Southampton is trialing a point-of-care biosensor test for flu, COVID-19, and RSV, delivering results in four minutes, according to the hospital.
The rapid PCR test delivers results up to 75% faster than other point-of-care HCV diagnostics, enabling same-day treatment initiation.
The collaboration will provide quality assessment products to support the commercialization of a molecular point-of-care assay for COVID-19 and influenza detection.
At ADLM, researchers showcase how AI is advancing clinical lab medicine—from improving early Lyme disease detection to helping teens access reliable health information.
Molecular sensor releases thyme flavor when encountering influenza virus, potentially enabling at-home screening through gum or lozenges.
New assays detect common bacterial causes of infectious gastroenteritis using molecular technology on existing diagnostic platforms.
The test uses Abbott's simpli-COLLECT platform to detect chlamydia, gonorrhea, trichomonas, and mycoplasma genitalium from patient-collected specimens.